🔎 Trials Near Me

Akèy › Kansè tiwoyid papilè

Etid klinik pou Kansè tiwoyid papilè ap rekrite nan Etazini

7 etid pou Kansè tiwoyid papilè ap rekrite patisipan nan sit atravè Etazini.

Vil ki gen plis etid

Pa eta

Etid ki fèk mete ajou

Tèks ofisyèl etid la (Anglè)

Radiofrequency Ablation for Management of Benign/Indeterminate Thyroid Nodules and Low Risk Papillary Thyroid Cancers

Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT07140757

Studies on Tumors of the Thyroid

Ap rekriteEtid obsèvasyon
6 Months – 98 Years · Tout sèks · Mizajou Aug 31, 2026 · NCT00001160

XL092 for the Treatment of Locally Advanced or Metastatic Radioiodine Refractory Differentiated Thyroid Cancer

Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jun 26, 2026 · NCT06959641

Targeted Therapy to Increase RAI Uptake in Metastatic DTC

Ap rekriteEtid obsèvasyon
Laj 0 ak plis · Tout sèks · Mizajou Nov 14, 2025 · NCT05024929

Restor. I-131 Upt. + Selpercatinib in RET F-P RAI-R TC

Ap rekriteFaz 2
Laj 12 ak plis · Tout sèks · Mizajou Dec 12, 2024 · NCT05668962

Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.